Regulation & law · 19/11/2020
Catalent Pharma Solutions Receives Authorization to Expand Production in New Jersey FTZ
Catalent Pharma Solutions, a leading pharmaceutical products manufacturer, has been authorized to expand its production activities in the Foreign-Trade Zone (FTZ) 49-Newark and Elizabeth, New Jersey, further solidifying its presence in the region.